BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21338604)

  • 1. Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.
    Brumlik MJ; Nkhoma S; Kious MJ; Thompson GR; Patterson TF; Siekierka JJ; Anderson TJ; Curiel TJ
    Exp Parasitol; 2011 Jun; 128(2):170-5. PubMed ID: 21338604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.
    Wei S; Daniel BJ; Brumlik MJ; Burow ME; Zou W; Khan IA; Wadsworth S; Siekierka J; Curiel TJ
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4324-8. PubMed ID: 17923491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication.
    Wei S; Marches F; Daniel B; Sonda S; Heidenreich K; Curiel T
    Int J Parasitol; 2002 Jul; 32(8):969-77. PubMed ID: 12076626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of chloroquine and mefloquine resistance in Plasmodium falciparum by the two monoindole alkaloids, icajine and isoretuline.
    Frédérich M; Hayette MP; Tits M; De Mol P; Angenot L
    Planta Med; 2001 Aug; 67(6):523-7. PubMed ID: 11509972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
    Khairul MF; Min TH; Low JH; Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
    Jpn J Infect Dis; 2006 Oct; 59(5):329-31. PubMed ID: 17060702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.
    Famin O; Ginsburg H
    Biochem Pharmacol; 2002 Feb; 63(3):393-8. PubMed ID: 11853690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo properties of ellagic acid in malaria treatment.
    Soh PN; Witkowski B; Olagnier D; Nicolau ML; Garcia-Alvarez MC; Berry A; Benoit-Vical F
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1100-6. PubMed ID: 19015354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil.
    Goldring JD; Padayachee T; Ismail I
    Mem Inst Oswaldo Cruz; 1999; 94(5):667-74. PubMed ID: 10464415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibitors of malarial P. Falciparum protein kinase G: Improving the cell activity of a series of imidazopyridines.
    Large JM; Birchall K; Bouloc NS; Merritt AT; Smiljanic-Hurley E; Tsagris DJ; Wheldon MC; Ansell KH; Coombs PJ; Kettleborough CA; Whalley D; Stewart LB; Bowyer PW; Baker DA; Osborne SA
    Bioorg Med Chem Lett; 2019 Feb; 29(3):509-514. PubMed ID: 30553738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
    Traoré K; Diakité SAS; Bah S; Konaté DS; Dabitao D; Sanogo I; Sangaré M; Dama S; Keita B; Doumbouya M; Guindo MA; Doumbia S; Diakité M
    Drugs R D; 2020 Sep; 20(3):249-255. PubMed ID: 32557086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum.
    Basco LK; Gillotin C; Gimenez F; Farinotti R; Le Bras J
    Br J Clin Pharmacol; 1992 May; 33(5):517-20. PubMed ID: 1524966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligands of the peripheral benzodiazepine receptor are potent inhibitors of Plasmodium falciparum and Toxoplasma gondii in vitro.
    Dzierszinski F; Coppin A; Mortuaire M; Dewailly E; Slomianny C; Ameisen JC; DeBels F; Tomavo S
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3197-207. PubMed ID: 12234845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.
    Alcantara LM; Kim J; Moraes CB; Franco CH; Franzoi KD; Lee S; Freitas-Junior LH; Ayong LS
    Exp Parasitol; 2013 Jun; 134(2):235-43. PubMed ID: 23541983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
    Wilson DW; Langer C; Goodman CD; McFadden GI; Beeson JG
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1455-67. PubMed ID: 23318799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
    Fivelman QL; Walden JC; Smith PJ; Folb PI; Barnes KI
    Trans R Soc Trop Med Hyg; 1999; 93(4):429-32. PubMed ID: 10674097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay.
    Briolant S; Parola P; Fusaï T; Madamet-Torrentino M; Baret E; Mosnier J; Delmont JP; Parzy D; Minodier P; Rogier C; Pradines B
    Malar J; 2007 Apr; 6():44. PubMed ID: 17437625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998.
    Schwenke A; Brandts C; Philipps J; Winkler S; Wernsdorfer WH; Kremsner PG
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):63-4. PubMed ID: 11233471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
    Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
    East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum.
    Boechat N; Ferreira Mde L; Pinheiro LC; Jesus AM; Leite MM; Júnior CC; Aguiar AC; de Andrade IM; Krettli AU
    Chem Biol Drug Des; 2014 Sep; 84(3):325-32. PubMed ID: 24803084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S; Walter RD; Müller S
    Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.